GTx Up Nearly 26% (GTXI)
Shares of GTx, Inc. (NASDAQ: GTXI) are soaring this morning after the tiny biotech company was upgraded at Citigroup.
At last check, shares of GTx, Inc. were up 73 cents to $3.48, a gain of 26.5%.
GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules to treat cancer, osteoporosis and bone loss, muscle loss, and other serious medical conditions.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.